Date: 2015-09-15
Type of information: Establishment of a new subsidiary in the EU
Compound:
Company: PharmaMar (Spain)
Therapeutic area: Cancer - Oncology
Type agreement: establishment of a new subsidiary in the EU
Action mechanism:
Disease:
Details: * On September 15t, 2015, PharmaMar announced the opening of a new office in London, UK, to strengthen its commercial activity in the European oncology market. This affiliate is the fifth office to be opened in Europe, and it will reinforce the presence of PharmaMar in the European territory, which is now supported by the Company´s direct presence in Italy, Germany, France, Switzerland and Spain, where PharmaMar is headquartered. With the new team in UK, PharmaMar will aim to provide a stronger medical support to the cancer community and to expand its commercial activity. According to the UK Office for National Statistics, 292,680 new cases of cancer were diagnosed in England in 2013. For male patients, the three most common cancers were prostate, lung and colorectal, and for female patients, these three cancers included breast as well as lung and colorectal.
Financial terms:
Latest news:
